1-12 of 12
Keywords: multiple myeloma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biosci Rep (2021) 41 (6): BSR-2018-2489_RET.
Published: 21 June 2021
... © 2021 The Author(s). 2021 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . miR-29b-3p multiple myeloma TUG1 This article is being retracted from...
Articles
Biosci Rep (2020) 40 (10): BSR20193563.
Published: 21 October 2020
... of the human cornea. CLSM screening was evaluated for early detection of corneal nerve morphology changes and neuropathogenic events in different stage multiple myeloma (MM) patients. As MM patients show disease as well as therapy-related neuropathological symptoms, CLSM potentially provides a tool for non...
Articles
Biosci Rep (2019) 39 (10): BSR20190284.
Published: 15 October 2019
...Bing Xia; Xi Wang; Ruifang Yang; Li Mengzhen; Kunpeng Yang; Li Ren; Suxia Li; Shuye Wang; Yizhuo Zhang The aim of the present study was to evaluate the relationship of Epstein–Barr virus (EBV) infection and multiple myeloma (MM) and its impact on clinical characteristics and prognosis. Fresh...
Articles
Biosci Rep (2019) 39 (5): BSR20190206.
Published: 31 May 2019
...Hirono Iriuchishima; Akito Maeshima; Shunsuke Takahashi; Takuma Ishizaki; Akihiko Yokohama; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa Renal impairment (RI) is a common complication of multiple myeloma (MM) that significantly affects treatment efficacy and mortality...
Articles
Biosci Rep (2019) 39 (5): BSR20181245.
Published: 14 May 2019
...Ning-Hong Guo; Ji-Fu Zheng; Fu-Ming Zi; Jing Cheng Background: Multiple myeloma (MM) is an incurable hematologic cancer, accompanied by excessive osteoclast formation and inflammatory cytokine secretion. The mechanisms by which bromodomain and extra-terminal domain (BET) protein inhibitor I-BET151...
Articles
Biosci Rep (2019) 39 (4): BSR20182502.
Published: 09 April 2019
...Feifei Che; Chunqian Wan; Jingying Dai; Jiao Chen Multiple myeloma (MM) is an incurable hematological malignancy characterized by abnormal infiltration of plasma cells in the bone marrow. MicroRNAs (miRNAs) have emerged as crucial regulators in human tumorigenesis and tumor progression. miR-27...
Articles
Biosci Rep (2019) 39 (3): BSR20181916.
Published: 22 March 2019
...Xiaoyang Sun; Yu Xie; Xiaoshen Sun; Yao Yao; Hujun Li; Zhenyu Li; Ruosi Yao; Kailin Xu Multiple myeloma (MM) is a hematological malignancy of plasma cells that produce a monoclonal immunoglobulin protein. Despite significant advances in the treatment of MM, challenges such as resistance to therapy...
Articles
Biosci Rep (2019) 39 (3): BSR20182489.
Published: 22 March 2019
...Dahai Liu; Jianfeng Wang; Meihan Liu Background : Long non-coding RNA taurine up-regulated gene 1 (TUG1) was reportedly involved in initiation and development of several cancers. However, its function and molecular mechanisms in multiple myeloma (MM) are still unclear. The present study aimed...
Articles
Biosci Rep (2018) 38 (5): BSR20181027.
Published: 19 September 2018
...Ruosi Yao; Xiaoyang Sun; Yu Xie; Xiaoshen Sun; Yao Yao; Hujun Li; Zhenyu Li; Jian Gao; Kailin Xu Increasing evidence shows that c-Myc oncoprotein is tightly associated with multiple myeloma (MM) progression. Herein, we identified compound 7594-0035, which is a novel inhibitor that specifically...
Articles
Biosci Rep (2018) 38 (3): BSR20171697.
Published: 31 May 2018
...Chen Tian; Lu Wang; Ling Wu; Lei Zhu; Wengui Xu; Zhaoxiang Ye; Zhigang Zhao; Yafei Wang; Yizhuo Zhang Multiple myeloma (MM) is a hematological neoplasm which results in diffuse or focal bone infiltration and extramedullary lesions. It’s reported that infiltration of organs by plasma cells indicated...
Articles
Biosci Rep (2017) 37 (4): BSR20170304.
Published: 27 July 2017
...Chun-yan Sun; Jun-ying Li; Zhang-bo Chu; Lu Zhang; Lei Chen; Yu Hu Multiple myeloma (MM) is a B-cell neoplasm with a high incidence of relapse. Bortezomib has been extensively studied for the maintenance treatment of MM. Here, we carried out a meta-analysis to determine the efficacy and safety...
Articles
Biosci Rep (2015) 35 (6): e00274.
Published: 08 December 2015
...Kévin Adam; Mireille Lambert; Elsa Lestang; Gabriel Champenois; Isabelle Dusanter-Fourt; Jérôme Tamburini; Didier Bouscary; Catherine Lacombe; Yael Zermati; Patrick Mayeux The oncogenic Pim2 kinase is overexpressed in several haematological malignancies, such as multiple myeloma and acute myeloid...
Includes: Supplementary data